Literature DB >> 15457552

Transfection of p27kip1 enhances radiosensitivity induced by 60Co gamma-irradiation in hepatocellular carcinoma HepG2 cell line.

Xiao-Xiang Guan1, Long-Bang Chen, Gui-Xia Ding, Wei De, Ai-Hua Zhang.   

Abstract

AIM: To study the cell cycle alterations of human hepatoma cell line HepG(2) in vitro after (60)Co gamma-irradiation and further to examine the mechanisms underlying the enhancement of radiosensitivity to gamma-irradiation in HepG(2) transiently transfected with wild type p27(kip1).
METHODS: The proliferation of HepG(2) cells was evaluated with MTT assay, and the cell cycle profile and apoptosis were assessed by cell morphology, DNA fragmentation analysis and flow cytometry. HepG(2) cells were transfected with p27(kip1) wild type by using Lipofectamine (LF2000), and the expression and subcellular localization of p27(kip1) in HepG(2) were detected by immunocytochemistry.
RESULTS: (60)Co gamma-irradiation inhibited the growth of HepG(2) cells in a dose-dependent manner. Apoptosis of HepG(2) cells was induced 48 h after gamma ray exposure. Furthermore research was carried out to induce exogenous expression of p27(kip1) in HepG(2). The expression of p27(kip1) induced G(0)/G(1) phase arrest in HepG(2) cells. The overexpression of p27(kip1) enhanced (60)Co gamma-irradiation-induced radiosensitivity in HepG(2) cells.
CONCLUSION: Overexpression of p27(kip1) is a rational approach to improve conventional radiotherapy outcomes, which may be a possible strategy for human hepatoma therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15457552      PMCID: PMC4611250          DOI: 10.3748/wjg.v10.i21.3103

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

Authors:  T Takayama; T Sekine; M Makuuchi; S Yamasaki; T Kosuge; J Yamamoto; K Shimada; M Sakamoto; S Hirohashi; Y Ohashi; T Kakizoe
Journal:  Lancet       Date:  2000-09-02       Impact factor: 79.321

2.  Efficient and cancer-selective gene transfer to hepatocellular carcinoma in a rat using adenovirus vector with iodized oil esters.

Authors:  H Shiba; T Okamoto; Y Futagawa; T Ohashi; Y Eto
Journal:  Cancer Gene Ther       Date:  2001-10       Impact factor: 5.987

3.  Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.

Authors:  Y H Huang; J C Wu; W Y Lui; G Y Chau; S H Tsay; J H Chiang; K L King; T I Huo; F Y Chang; S D Lee
Journal:  World J Surg       Date:  2000-05       Impact factor: 3.352

Review 4.  Epidemiology of hepatocellular carcinoma.

Authors:  H B el-Serag
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

5.  Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma.

Authors:  K Hanazaki; S Kajikawa; N Shimozawa; M Mihara; K Shimada; M Hiraguri; N Koide; W Adachi; J Amano
Journal:  J Am Coll Surg       Date:  2000-10       Impact factor: 6.113

Review 6.  Molecular therapy and prevention of hepatocellular carcinoma.

Authors:  Hubert E Blum
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2003-02

7.  A recombinant adenovirus expressing p7(Kip1) induces cell cycle arrest and apoptosis in human 786-0 renal carcinoma cells.

Authors:  Adrienne L Katner; Praveen Gootam; Quoc Bao Ly Hoang; James R Gnarra; Walter Rayford
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

8.  Adenovirus expressing mutant p27kip1 enhanced apoptosis against cholangiocarcinoma than adenovirus-p27kip1 wild type.

Authors:  Tsuyoshi Sasaki; Yu Katayose; Masanori Suzuki; Kuniharu Yamamoto; Satoru Shiraso; Masamichi Mizuma; Michiaki Unno; Heigo Takeuchi; Choon-Taek Lee; Seiki Matsuno
Journal:  Hepatogastroenterology       Date:  2004 Jan-Feb

9.  Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice.

Authors:  V Schmitz; L Wang; M Barajas; C Gomar; J Prieto; C Qian
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

10.  p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

Authors:  M V Ponce-Castañeda; M H Lee; E Latres; K Polyak; L Lacombe; K Montgomery; S Mathew; K Krauter; J Sheinfeld; J Massague
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.